pharma news, views and analysis - pharmaphorum.com

Trending

in News
Theravance axes staff as lead pipeline drug flunks phase 3 trial
September 15, 2021 Share
X
Theravance axes staff as lead pipeline drug flunks phase 3 trial
https://pharmaphorum.com/news/theravance-axes-staff-as-lead-pipeline-drug-flunks-phase-3-trial/
in News
Rome Therapeutics raises $77m for junk DNA-targeting drugs
September 14, 2021 Share
X
Rome Therapeutics raises $77m for junk DNA-targeting drugs
https://pharmaphorum.com/news/rome-therapeutics-raises-77m-for-junk-dna-targeting-drugs/

Latest News

First subject dosed in psilocybin trial for rare headache disorder

First subject dosed in psilocybin trial for rare headache disorder

The first patient has received a low dose of Beckley Psytech’s psychedelic medicine psilocybin in a clinical trial

X

First subject dosed in psilocybin trial for rare headache disorder

https://pharmaphorum.com/news/first-subject-dosed-in-psilocybin-trial-for-rare-headache-disorder/

AbbVie spies potential in Regenxbio eye disease gene therapy

AbbVie spies potential in Regenxbio eye disease gene therapy

AbbVie has expanded its ophthalmology pipeline via a licensing deal with Regenxbio, paying $370 million upfront to get

X

AbbVie spies potential in Regenxbio eye disease gene therapy

https://pharmaphorum.com/news/abbvie-spies-potential-in-regenxbio-eye-disease-gene-therapy/

Apellis reports mixed data with eye drug, but plans to file anyway

Apellis reports mixed data with eye drug, but plans to file anyway

Apellis Pharma has reported mixed results with its lead drug pegcetacoplan in geographic atrophy (GA) – a major

X

Apellis reports mixed data with eye drug, but plans to file anyway

https://pharmaphorum.com/news/apellis-reports-mixed-data-with-eye-drug-but-plans-to-file-anyway/

Views & Analysis

France’s biotech ecosystem is primed for growth – it’s time to feed it

France’s biotech ecosystem is primed for growth – it’s time to feed it

After some years of stagnant funding and growth France is now at an inflection point for health care

X

France’s biotech ecosystem is primed for growth – it’s time to feed it

https://pharmaphorum.com/r-d/france-biotech-ecosystem-jeito-capital/

Biotech Insight podcast: Overcoming planning challenges in oncology

Biotech Insight podcast: Overcoming planning challenges in oncology

The first episode of Kantar Health’s new Biotech Insight podcast takes aim at the planning and forecasting challenges

X

Biotech Insight podcast: Overcoming planning challenges in oncology

https://pharmaphorum.com/podcast/biotech-insight-oncology-planning/

Targeting COVID-19 and cancer with immunotherapy advancements

Targeting COVID-19 and cancer with immunotherapy advancements

Anna Biosciences’ Dr Anthony Rullo discusses the drug development company’s immunotherapy platform. Over the last 30 years, we

X

Targeting COVID-19 and cancer with immunotherapy advancements

https://pharmaphorum.com/r-d/targeting-covid-19-cancer-immunotherapy-advancements/

Debates & Insights

Customer engagement and pharma’s field force future

Customer engagement and pharma’s field force future

How healthcare professionals (HCPs) prefer to engage with pharma companies has been changing for some time, and COVID’s

X

Customer engagement and pharma’s field force future

https://pharmaphorum.com/webinars/axtria-customer-engagement-pharmas-field-force-future-digital-transformation/

AI, big data and deep real-world evidence – the challenges and opportunities

AI, big data and deep real-world evidence – the challenges and opportunities

Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights

X

AI, big data and deep real-world evidence – the challenges and opportunities

https://pharmaphorum.com/webinars/ai-big-data-real-world-evidence-savana/

Virtual trials and the next generation of pharma clinical research

Virtual trials and the next generation of pharma clinical research

Previously viewed as a ‘nice to have’ for the pharma industry, virtual trials were already moving from a

X

Virtual trials and the next generation of pharma clinical research

https://pharmaphorum.com/webinars/nihr-virtual-trials-pharma-research/

Partner Content

Cell-Mediated Therapies for Infectious Disease Summit

Cell-Mediated Therapies for Infectious Disease Summit

Cell-Mediated Therapies for Infectious Disease Summit

X

Cell-Mediated Therapies for Infectious Disease Summit

https://pharmaphorum.com/events/cell-mediated-therapies-for-infectious-disease-summit/

Induced Proximity-Based Drug Discovery Summit

Induced Proximity-Based Drug Discovery Summit

Induced Proximity-Based Drug Discovery Summit

X

Induced Proximity-Based Drug Discovery Summit

https://pharmaphorum.com/events/induced-proximity-based-drug-discovery-summit/

J+D FORECASTING MAKES THE PHARMA FORECASTING EXPERIENCE EVEN BETTER

J+D FORECASTING MAKES THE PHARMA FORECASTING EXPERIENCE EVEN BETTER

FC+, Pharma Forecasting Software has been upgraded

X

J+D FORECASTING MAKES THE PHARMA FORECASTING EXPERIENCE EVEN BETTER

https://pharmaphorum.com/partner-content/jd-forecasting-makes-the-pharma-forecasting-experience-even-better/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com